Recombinant Vaccines Market Report

China Recombinant Vaccines Industry Market Research Report 2023-2029

  • POSTDATE：Sep 06, 2023
  • PAGES：224
  • REPORT CODE：GMM1779686
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Recombinant vaccines are one of the most important tools in the medical industry today. These vaccines help prevent the spread of many infectious diseases, such as hepatitis B. In recent years, the growth of the market has been driven by a sharp increase in the incidence of infectious diseases, increased regulatory approvals, increased awareness of health care, and continued innovation in drug and vaccine development.

    This report elaborates on the current development of the Recombinant Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck & Co, Inc

    • Novartis AG

    • Sanofi S A

    • Protein Science Corporation

    • GlaxoSmithKline Plc

    • Bayer AG

    • Green Cross Corporation

    • Bharat Biotech

    By Type:

    • Subunit Recombinant Vaccines

    • Attenuated Recombinant Vaccines

    • Vector Recombinant Vaccines

    By Application:

    • Hospitals & clinics

    • Pediatrics

    • Veterinary

    • Others

    • Adults

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Recombinant Vaccines Market Overview 2018-2029

    • 1.1 China Recombinant Vaccines Industry Development Overview

    • 1.2 China Recombinant Vaccines Industry Development History

    • 1.3 China Recombinant Vaccines Industry Market Size (2018-2029)

    • 1.4 China Recombinant Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Recombinant Vaccines Production Volume, Production Value and Growth Rate of Subunit Recombinant Vaccines (2018-2029)

      • 1.4.2 China Recombinant Vaccines Production Volume, Production Value and Growth Rate of Attenuated Recombinant Vaccines (2018-2029)

      • 1.4.3 China Recombinant Vaccines Production Volume, Production Value and Growth Rate of Vector Recombinant Vaccines (2018-2029)

    • 1.5 China Recombinant Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals & clinics (2018-2029)

      • 1.5.2 China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Pediatrics (2018-2029)

      • 1.5.3 China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Veterinary (2018-2029)

      • 1.5.4 China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.5 China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)

    • 1.6 China Recombinant Vaccines Market Analysis by Region

      • 1.6.1 North China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Recombinant Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Recombinant Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Recombinant Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Recombinant Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Recombinant Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Recombinant Vaccines Industry Development

    Chapter 3 Recombinant VaccinesIndustry Chain Analysis

    • 3.1 Recombinant Vaccines Industry Chain

    • 3.2 Recombinant Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Recombinant Vaccines Market

    • 3.3 Recombinant Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Recombinant Vaccines Market

    Chapter 4 China Recombinant Vaccines Market, by Type

    • 4.1 China Recombinant Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Recombinant Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Recombinant Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Recombinant Vaccines Production Volume and Growth Rate of Subunit Recombinant Vaccines

      • 4.5.2 China Recombinant Vaccines Production Volume and Growth Rate of Attenuated Recombinant Vaccines

      • 4.5.3 China Recombinant Vaccines Production Volume and Growth Rate of Vector Recombinant Vaccines

    Chapter 5 China Recombinant Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Recombinant Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Recombinant Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Recombinant Vaccines Market Size and Growth Rate of Hospitals & clinics

      • 5.5.2 China Recombinant Vaccines Market Size and Growth Rate of Pediatrics

      • 5.5.3 China Recombinant Vaccines Market Size and Growth Rate of Veterinary

      • 5.5.4 China Recombinant Vaccines Market Size and Growth Rate of Others

      • 5.5.5 China Recombinant Vaccines Market Size and Growth Rate of Adults

    Chapter 6 China Recombinant Vaccines Market, by Region

    • 6.1 China Recombinant Vaccines Production Volume and Production Value, by Region

    • 6.2 China Recombinant Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Recombinant Vaccines Market Analysis

    • 7.1 North China Recombinant Vaccines Market, by Type

    • 7.2 North China Recombinant Vaccines Market, by Application

    Chapter 8 Central China Recombinant Vaccines Market Analysis

    • 8.1 Central China Recombinant Vaccines Market, by Type

    • 8.2 Central China Recombinant Vaccines Market, by Application

    Chapter 9 South China Recombinant Vaccines Market Analysis

    • 9.1 South China Recombinant Vaccines Market, by Type

    • 9.2 South China Recombinant Vaccines Market, by Application

    Chapter 10 East China Recombinant Vaccines Market Analysis

    • 10.1 East China Recombinant Vaccines Market, by Type

    • 10.2 East China Recombinant Vaccines Market, by Application

    Chapter 11 Northeast China Recombinant Vaccines Market Analysis

    • 11.1 Northeast China Recombinant Vaccines Market, by Type

    • 11.2 Northeast China Recombinant Vaccines Market, by Application

    Chapter 12 Southwest China Recombinant Vaccines Market Analysis

    • 12.1 Southwest China Recombinant Vaccines Market, by Type

    • 12.2 Southwest China Recombinant Vaccines Market, by Application

    Chapter 13 Northwest China Recombinant Vaccines Market Analysis

    • 13.1 Northwest China Recombinant Vaccines Market, by Type

    • 13.2 Northwest China Recombinant Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck & Co, Inc

        • 14.1.1 Merck & Co, Inc Company Profile

        • 14.1.2 Merck & Co, Inc Recombinant Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Novartis AG

        • 14.2.1 Novartis AG Company Profile

        • 14.2.2 Novartis AG Recombinant Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sanofi S A

        • 14.3.1 Sanofi S A Company Profile

        • 14.3.2 Sanofi S A Recombinant Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Protein Science Corporation

        • 14.4.1 Protein Science Corporation Company Profile

        • 14.4.2 Protein Science Corporation Recombinant Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 GlaxoSmithKline Plc

        • 14.5.1 GlaxoSmithKline Plc Company Profile

        • 14.5.2 GlaxoSmithKline Plc Recombinant Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bayer AG

        • 14.6.1 Bayer AG Company Profile

        • 14.6.2 Bayer AG Recombinant Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Green Cross Corporation

        • 14.7.1 Green Cross Corporation Company Profile

        • 14.7.2 Green Cross Corporation Recombinant Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bharat Biotech

        • 14.8.1 Bharat Biotech Company Profile

        • 14.8.2 Bharat Biotech Recombinant Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Recombinant Vaccines Industry Research Conclusions

    • 15.2 Recombinant Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Recombinant Vaccines Industry Market Size (2018-2029)

    • Figure China Recombinant Vaccines Production Volume, Production Value and Growth Rate of Subunit Recombinant Vaccines (2018-2029)

    • Figure China Recombinant Vaccines Production Volume, Production Value and Growth Rate of Attenuated Recombinant Vaccines (2018-2029)

    • Figure China Recombinant Vaccines Production Volume, Production Value and Growth Rate of Vector Recombinant Vaccines (2018-2029)

    • Figure China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals & clinics (2018-2029)

    • Figure China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Pediatrics (2018-2029)

    • Figure China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Veterinary (2018-2029)

    • Figure China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)

    • Figure North China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Recombinant Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Recombinant Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Recombinant Vaccines Market Share by Type in 2018

    • Figure China Recombinant Vaccines Market Share by Type in 2023

    • Figure China Recombinant Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Recombinant Vaccines Production Volume and Growth Rate of Subunit Recombinant Vaccines (2018-2023)

    • Figure China Recombinant Vaccines Production Volume and Growth Rate of Attenuated Recombinant Vaccines (2018-2023)

    • Figure China Recombinant Vaccines Production Volume and Growth Rate of Vector Recombinant Vaccines (2018-2023)

    • Figure China Recombinant Vaccines Market Share by Application in 2018

    • Figure China Recombinant Vaccines Market Share by Application in 2023

    • Figure China Recombinant Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Recombinant Vaccines Market Size and Growth Rate of Hospitals & clinics (2018-2023)

    • Figure China Recombinant Vaccines Market Size and Growth Rate of Pediatrics (2018-2023)

    • Figure China Recombinant Vaccines Market Size and Growth Rate of Veterinary (2018-2023)

    • Figure China Recombinant Vaccines Market Size and Growth Rate of Others (2018-2023)

    • Figure China Recombinant Vaccines Market Size and Growth Rate of Adults (2018-2023)

    • Table China Recombinant Vaccines Production Volume by Region (2018-2023)

    • Table China Recombinant Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Recombinant Vaccines Production Volume Share by Region (2018-2023)

    • Table China Recombinant Vaccines Production Value by Region (2018-2023)

    • Table China Recombinant Vaccines Production Value Share by Region (2018-2023)

    • Figure China Recombinant Vaccines Production Value Share by Region (2018-2023)

    • Table China Recombinant Vaccines Sales Volume by Region (2018-2023)

    • Table China Recombinant Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Recombinant Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Recombinant Vaccines Sales Value by Region (2018-2023)

    • Table China Recombinant Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Recombinant Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Recombinant Vaccines Production Volume by Type (2018-2023)

    • Table North China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Recombinant Vaccines Sales Volume by Application (2018-2023)

    • Table North China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Recombinant Vaccines Production Volume by Type (2018-2023)

    • Table Central China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Recombinant Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Recombinant Vaccines Production Volume by Type (2018-2023)

    • Table South China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Recombinant Vaccines Sales Volume by Application (2018-2023)

    • Table South China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Recombinant Vaccines Production Volume by Type (2018-2023)

    • Table East China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Recombinant Vaccines Sales Volume by Application (2018-2023)

    • Table East China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Recombinant Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Recombinant Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Recombinant Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Recombinant Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Recombinant Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Recombinant Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Recombinant Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Recombinant Vaccines Sales Volume Share by Application (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Recombinant Vaccines Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Recombinant Vaccines Revenue, Price and Gross (2018-2023)

    • Table Sanofi S A Company Profile

    • Table Sanofi S A Recombinant Vaccines Revenue, Price and Gross (2018-2023)

    • Table Protein Science Corporation Company Profile

    • Table Protein Science Corporation Recombinant Vaccines Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Plc Company Profile

    • Table GlaxoSmithKline Plc Recombinant Vaccines Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Recombinant Vaccines Revenue, Price and Gross (2018-2023)

    • Table Green Cross Corporation Company Profile

    • Table Green Cross Corporation Recombinant Vaccines Revenue, Price and Gross (2018-2023)

    • Table Bharat Biotech Company Profile

    • Table Bharat Biotech Recombinant Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US